Equillium, Inc. ( EQ) - Key Metrics
EQ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.04 | -$0.04 | -$0.04 |
| 2026Q1 | $0 | -$0.06 | -$0.04 | -$0.04 |
| 2025Q4 | $0 | -$0.04 | -$0.03 | -$0.03 |
| 2025Q3 | $0 | -$0.12 | -$0.24 | -$0.24 |
| 2025Q2 | $0 | -$0.16 | -$0.08 | -$0.08 |
EQ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -20 |
| 2026Q1 | 0% | -9.06 |
| 2025Q4 | 0% | -9.43 |
| 2025Q3 | 0% | -2.98 |
| 2025Q2 | 0% | -0.49 |
EQ
Price: $2.36
52 week price:
Earnings Per Share: -0.09 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 25774
Market Capitalization: 149.6 million